PROM1 and lung cancer: High invasiveness of CD133 (+) colonies in lung cancer PDO are also associated with activation of AXL, TGFβ, and JAK1, proofed by effective treatment of AXL inhibitor TP-0903 and JAK inhibitor Ruxolitinib [33].